Pfizer and Mylan combo company expected to rake in $20bn in 2020
Pfizer creates ‘new champion for global health’ through the combining of its business unit and Mylan to establish a pharmaceutical company.
Archives for July 29, 2019
Veristat opens office in Taiwan to support ‘fast-growing' clinical development market
Veristat launches clinical trial, biostatistics, and programming operations in Taipei, Taiwan in response to increasing client demand for regulatory submission support for both local and North American-based sponsors.
Global infectious disease drug development partnership aims to ‘stimulate pharma’
Penta and Cromsource partner in an aim to improve pediatric drug development for infectious disease therapies worldwide.
ClinOne lauching direct-to-patient recruitment platform in 2020
ClinOne is launching a direct-to-patient recruitment platform, which will initially be offered at no cost to sponsors for the first year.
Gilead keeps doing deals, adding Novartis’ antivirals
Gilead continues to bolster its pipeline of products by licensing three preclinical antiviral programs from Novartis for three separate infections.
Investment from AI Fund enables development of non-traditional drug candidates for depression
O2h Ventures and AI Fund invest in Small Pharma, as it works to complete studies for its lead program, a metabolite of ketamine as an oral anti-depressant.